trial · primary record
Ivarmacitinib Sulfate Tablets
Refractory Metastatic Colorectal Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 33 |
| Primary completion | 2028-06-30 |
| Primary endpoint | PFS |
| Registry ID | NCT07896096 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:28.810Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07896096
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.